Lotus Pharm vs Sofiva Genomics: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Sofiva Genomics (6615) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Sofiva Genomics

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYSofiva GenomicsYoY
Oct 2026NT$2.13 billion-22.5%NT$30.2 million-3.0%
Sep 2026NT$2.77 billion+128.0%NT$30.5 million+1.8%
Aug 2026NT$2.11 billion+81.7%NT$30.4 million-2.4%
Jul 2026NT$2.49 billion+3.9%NT$33.7 million+4.3%
Jun 2026NT$3.4 billion+225.5%NT$32.3 million-2.5%
May 2026NT$2.32 billion+105.8%NT$33.7 million-1.7%
Apr 2026NT$3.09 billion+19.9%NT$30.2 million-9.1%
Mar 2026NT$4.35 billion+173.6%NT$34.4 million+2.8%
Feb 2026NT$2.24 billion+131.5%NT$26.4 million-15.7%
Jan 2026NT$2.05 billion-5.5%NT$33.1 million+6.3%
Dec 2025NT$2.44 billion+66.9%NT$33.7 million-3.4%
Nov 2025NT$1.06 billion-0.2%NT$30.9 million-4.9%
Oct 2025NT$2.75 billion+46.0%NT$31.1 million-13.9%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16